在线QQ: 五斗堂面馆
    专题栏目
    专业术语
    ISPN词汇 小儿血液系统疾病
    ISPN词汇 小儿肌肉骨骼系统疾病
    出国资讯
    美国宣布重大移民改革议案取消公民...
    2017美国护士薪资调查报告新鲜出炉
    医护前沿
    《ISPN学习》总第506期
    《ISPN学习》总第505期
     
    当前位置:首页 > ISPN学习
    《RN-ISPN学习》总第797期
    日期:2021-07-09 14:12:00    
     
    《RN-ISPN学习》2021年07月09日总第797期
     
      
    ———— Vocabulary ————
     
    automaticity – n. 自动节律性
    conductivity – n. 传导性
    proarrhythmic – a. 致心律失常的
    hemodynamic – n. 血流动力学
    CAST -- Cardiac Arrhythmia Suppression Trial
    CAST – 心律失常抑制试验
    reflex arrhythmias – 反射性节律异常

     
    RN-ISPN考试复习要点提示
    帮助您尽快理清复习思路,准确抓住复习重点,是ISPN/RN考试复习的一大利器!
     
     
     
    ———— RN/ISPN Review ————
     
    Antiarrhythmic Agents
    抗心律不齐药            
     
    Antiarrhythmics affect the action potential of the cardiac cells by altering their automaticity, conductivity, or both. Because of this effect, antiarrhythmic drugs can also produce new arrhythmias—that is, they are proarrhythmic. Antiarrhythmics are used in emergency situations when the hemodynamics arising from the patient’s arrhythmia are severe and could potentially be fatal.

    抗心律不齐药通过改变心肌细胞自动节律、传导性或两者皆变,影响心肌细胞动作电位。由于这一效应,抗心律不齐药还可以产生新的心律不齐,即这些药物也有致心律失常性。在患者心律不齐引起的血流动力学严重受损严重,可能具有潜在致命性等紧急情况时,也可使用抗心律不齐药。

    Antiarrhythmics were widely used on a long-term basis to suppress any abnormal arrhythmia, until the publication of the Cardiac Arrhythmia Suppression Trial (CAST) in the early 1990s. This multicenter, randomized, long-term study conducted by the National Heart, Lung, and Blood Institute looked at the mortality rate of patients with asymptomatic, non–life-threatening arrhythmias being treated with antiarrhythmics. The results showed that long-term use of some antiarrhythmics was associated with an increased risk of death. In fact, the risk of death for some patients was two to three times greater than that for untreated patients. These results prompted more clinical trials to look at the effectiveness of long-term use of antiarrhythmics.

    抗心律不齐药广泛用于长期治疗,抑制任何异常的心律不齐,直到1990年代初发表心律失常抑制试验(CAST)报告。由国家心、肺和血液研究所进行的多中心随机长期研究对接受抗心律不齐药治疗的无症状、非威胁生命心律不齐患者的死亡率进行了研究。结果显示,长期使用某些抗心律不齐药与死亡危险增加存在相关性。事实上,某些患者的死亡危险是未治疗患者的2-3倍以上。这些结果促使人们进行更多的临床试验,以检查抗心律不齐药的长期使用效果。

    It was found that antiarrhythmics may block some reflex arrhythmias that help to keep the cardiovascular system in balance, or they may precipitate new, deadly arrhythmias. Therefore, it is important to document the arrhythmia being treated and the rationale for treatment and to monitor a patient regularly when using these drugs.

    研究发现,抗心律不齐药可能阻断某些反射性心律不齐,这些心律不齐帮助保持心血管系统的平衡,也可能触发新的致命性心律不齐。因此,使用药物期间,记录正在治疗的心律不齐及治疗原理,定期监测患者,这一点非常重要。


    ———— Video ————
     
    Antiarrhythmic Class I-II
     
     
    ———— Tests ————
     
    1. Conduction defects will most likely be an adverse associated with the use of:
    A. Verapamil (Isoptin)
    B. Nifedipine (Adalat CC)
    C. Diltiazem (Cardizem)
    D. Felodipine (Plendil)
    2. Jason James is taking ß blockers, all of the following should be included in his assessment except:
    A. Pulmonary function tests.
    B. Baseline ECG.
    C. Glucose level.
    D. Blood pressure.
     

     
    奥医教育“在线自测”题库
    I
    SPN/RN复习练习、效果检验一站完成。
     
     
    答案Answer
    1. A. Verapamil (Isoptin).
    Rationale: Verapamil (Isoptin) has the strongest chronotropic effect and will cause a delay in conduction at the SA and AV nodes. Verapamil also increases myocardial oxygen delivery, which helps patients with vasospastic angina. Verapamil correlates with negative chronotropic effects and a decrease in sympathetic nervous system activity.
    2. A. Pulmonary function tests.
    Rationale: Unless the client has a history of pulmonary disease and pulmonary function tests are indicated, there is no need to include this in the routine assessment of the client taking ß blockers. Beta-blockers, as a class of drugs, are primarily used to treat cardiovascular diseases and other conditions.





    上一篇:《RN-ISPN学习》总第796期
    下一篇:《RN-ISPN学习》总第798期